PSA levels and PSMA PET/CT in prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how PSA levels (a blood test marker for prostate cancer) relate to images from a special scan called F-18 PSMA PET/CT. It helps doctors understand what the scan results mean for your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed prostate cancer diagnosis (from a biopsy).
- Your doctor has referred you for a PSMA PET/CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.
This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.
This study uses a special type of PET/CT scan called 18F-PSMA-1007 to take detailed pictures of prostate cancer. It's for people who might have prostate cancer, have been diagnosed, or need to check how their cancer is doing after treatment.
This study looks at how well a special scan (PSMA PET/CT) works for people with cancers other than prostate cancer. If your doctor already scheduled this scan for your care, you may be able to help researchers learn more about its accuracy.
This study compares a special type of PET/CT scan (using a tracer called 18F-PSMA) with a regular CT scan to see which is better at checking for prostate cancer spread. It may help improve how your cancer is monitored.
This trial compares two types of PET/CT scans (using different radioactive tracers) to see which is better at finding prostate cancer, tracking its return, or spotting spread. It's for people with prostate cancer or those being checked for recurrence after treatment.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.